RETRACTED: Self-assembled phenylalanine-α,β-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor
- 25 September 2013
- journal article
- retracted article
- Published by Elsevier in Journal of Controlled Release
- Vol. 172 (3) , 1151-1160
Abstract
No abstract availableKeywords
Funding Information
- NIH (EY018940, EY017533)
This publication has 55 references indexed in Scilit:
- Modulating Adaptive Immune Responses to Peptide Self-AssembliesACS Nano, 2012
- Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakageMicrovascular Research, 2011
- Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseasesDrug Delivery and Translational Research, 2010
- Micro-Flow Imaging: Flow Microscopy Applied to Sub-visible Particulate Analysis in Protein FormulationsThe AAPS Journal, 2010
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III TrialJournal of Clinical Oncology, 2010
- Subconjunctival Nanoparticle Carboplatin in the Treatment of Murine RetinoblastomaArchives of Ophthalmology (1950), 2009
- Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor PazopanibArchives of Ophthalmology (1950), 2009
- The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myelomaProceedings of the National Academy of Sciences, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Issues related to targeted delivery of proteins and peptidesThe AAPS Journal, 2006